General Biotechnology

General Biotechnology

Own the Clock: How Pharma Companies Extract Maximum Value from Patent Term Extensions and Secondary Patents

In the fiercely competitive world of pharmaceuticals, every second counts. As patent cliffs loom and generic competitors threaten market share, pharma giants are turning to sophisticated legal and strategic maneuvers to extend their dominance. The late…

Own the Clock: How Pharma Companies Extract Maximum Value from Patent Term Extensions and Secondary Patents Read Post »

Biotechblog
Scroll to Top